$AIDX SEC Filings

Filed On	Filing
21 Oct 2026	DEFINITIVE ADDITIONAL MATERIALS
21 Oct 2026	Proxy statement: special meeting on December 9, 2026
06 Oct 2026	PRELIMINARY PROXY STATEMENT
18 Sep 2026	8-K: Submission of Matters to a Vote of Security Holders As previously disclosed, on August 18, 2026, 20/20 Biolabs, Inc. (the “Company”) convened its annual meeting of stockholders of the Company (the “Annual Meeting”). At the Annual Meeting, the Company did not receive a sufficient number of...
10 Sep 2026	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
02 Sep 2026	8-K: Regulation FD Disclosure
19 Aug 2026	DEFINITIVE ADDITIONAL MATERIALS
19 Aug 2026	8-K: Submission of Matters to a Vote of Security Holders
17 Aug 2026	PROSPECTUS SUPPLEMENT
17 Aug 2026	PROSPECTUS SUPPLEMENT
17 Aug 2026	8-K: Results of Operations and Financial Condition
14 Aug 2026	QUARTERLY REPORT
05 Aug 2026	8-K: Regulation FD Disclosure
22 Jul 2026	8-K: Entry into a Material Definitive Agreement; Notice of Delisting or Failure to Satisfy a Listing Rule
01 Jul 2026	8-K: Regulation FD Disclosure
23 Jun 2026	DEFINITIVE ADDITIONAL MATERIALS
23 Jun 2026	Proxy statement: annual meeting on August 18, 2026
01 Jun 2026	PRELIMINARY PROXY STATEMENT
26 May 2026	8-K: Material Modification to Rights of Security Holders; Amendments to Articles/Bylaws; Change in Fiscal Year
21 May 2026	PROSPECTUS SUPPLEMENT

Comments